Sec. 8023. Unfair or deceptive acts or practices with respect to substance use disorder treatment service and products
197 words·~1 min read·
/bill/115/hr/6/eah/section-8023A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
It is unlawful to engage in an unfair or deceptive act or practice with respect to any substance use disorder treatment service or substance use disorder treatment product. A violation of subsection
(a)shall be treated as a violation of a rule under section 18 of the Federal Trade Commission Act ( 15 U.S.C. 57a ) regarding unfair or deceptive acts or practices. The Federal Trade Commission shall enforce this section in the same manner, by the same means, and with the same jurisdiction, powers, and duties as though all applicable terms and provisions of the Federal Trade Commission Act ( 15 U.S.C. 41 et seq.) were incorporated into and made a part of this section. Any person who violates subsection
(a)shall be subject to the penalties and entitled to the privileges and immunities provided in the Federal Trade Commission Act as though all applicable terms and provisions of the Federal Trade Commission Act ( 15 U.S.C. 41 et seq.) were incorporated and made part of this section. Nothing in this subtitle shall be construed to limit the authority of the Federal Trade Commission or the Food and Drug Administration under any other provision of law.
Connectionstraces to 2
Citation graph
cites case law
Sec. 8023
Unfair or deceptive acts or practices with respect to substance use disorder treatment service and products
Cites 2Cited by 0 across 0 sources